ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Obstetrics Gynecology

Top Obstetrics Gynecology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LORAINE DIEGO MD

Obstetrics Gynecology

9,948

$542K

310
174 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

19%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

20%
prescriptions for brand name drugs

Avg: 44%

$54
Average prescription price

Avg: $89

ILEANA SHAW MD

Obstetrics Gynecology

6,894

$296K

324
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

17%
prescriptions for brand name drugs

Avg: 44%

$43
Average prescription price

Avg: $89

JOSEPH SPRACHER MD

Obstetrics Gynecology

3,691

$305K

243
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

15%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

32%
prescriptions for brand name drugs

Avg: 44%

$83
Average prescription price

Avg: $89

MARK GARRISON DO

Obstetrics Gynecology

2,496

$174K

257
185 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

28%
prescriptions for brand name drugs

Avg: 44%

$70
Average prescription price

Avg: $89

JOHNNIE HAM M.D.

Obstetrics Gynecology

1,937

$198K

90
51 are 65+

14%
patients receiving schedule two controlled substances

Avg: 0%

33%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

29%
prescriptions for brand name drugs

Avg: 44%

$102
Average prescription price

Avg: $89

CO PHAM MD

Obstetrics Gynecology

1,756

$206K

184
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

54%
prescriptions for brand name drugs

Avg: 44%

$117
Average prescription price

Avg: $89

VERONICA ABUSLEME M.D.

Obstetrics Gynecology

1,681

$114K

226
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

35%
prescriptions for brand name drugs

Avg: 44%

$68
Average prescription price

Avg: $89

SHERRY THOMAS MD MPH

Obstetrics Gynecology

1,635

$141K

262
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

49%
prescriptions for brand name drugs

Avg: 44%

$86
Average prescription price

Avg: $89

ELIAS MOUKARZEL M.D.

Obstetrics Gynecology

1,548

$171K

281
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

32%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

57%
prescriptions for brand name drugs

Avg: 44%

$111
Average prescription price

Avg: $89

CHRISTOPHER SMALE M.D.

Obstetrics Gynecology

1,375

$70.2K

133
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

33%
prescriptions for brand name drugs

Avg: 44%

$51
Average prescription price

Avg: $89

RIGOBERTO GUTIERREZ

Obstetrics Gynecology

1,346

$62.4K

98
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

21%
prescriptions for brand name drugs

Avg: 44%

$46
Average prescription price

Avg: $89

MARTHA GARCIA M.D.

Obstetrics Gynecology

1,322

$60.1K

86
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

21%
prescriptions for brand name drugs

Avg: 44%

$45
Average prescription price

Avg: $89

JUDITH BLISS

Obstetrics Gynecology

1,304

$453K

139
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

40%
prescriptions for brand name drugs

Avg: 44%

$347
Average prescription price

Avg: $89

KAREN DONLEY M.D.

Obstetrics Gynecology

1,253

$100K

235
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

42%
prescriptions for brand name drugs

Avg: 44%

$80
Average prescription price

Avg: $89

RISA KAGAN M.D,

Obstetrics Gynecology

1,234

$137K

248
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

69%
prescriptions for brand name drugs

Avg: 44%

$111
Average prescription price

Avg: $89

PARVIN MIRABADI MD

Obstetrics Gynecology

1,149

$112K

201
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

38%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

50%
prescriptions for brand name drugs

Avg: 44%

$97
Average prescription price

Avg: $89

MARKI KNOX M.D.

Obstetrics Gynecology

1,147

$112K

185
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

22%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

68%
prescriptions for brand name drugs

Avg: 44%

$98
Average prescription price

Avg: $89

GARY TOIG M.D.

Obstetrics Gynecology

1,114

$87.8K

81
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

41%
prescriptions for brand name drugs

Avg: 44%

$79
Average prescription price

Avg: $89

SHARON KNIGHT M.D.

Obstetrics Gynecology

1,084

$137K

285
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

40%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

55%
prescriptions for brand name drugs

Avg: 44%

$126
Average prescription price

Avg: $89

KAREN TUAN M.D.

Obstetrics Gynecology

1,041

$222K

347
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

29%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

59%
prescriptions for brand name drugs

Avg: 44%

$213
Average prescription price

Avg: $89

TIFFANY TRAN MD

Obstetrics Gynecology

1,017

$38.6K

137
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

16%
prescriptions for brand name drugs

Avg: 44%

$38
Average prescription price

Avg: $89

LESLIE BALLARD M.D.

Obstetrics Gynecology

1,015

$37.3K

342
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

20%
prescriptions for brand name drugs

Avg: 44%

$37
Average prescription price

Avg: $89

FELICIA OTA M.D.

Obstetrics Gynecology

1,010

$80.2K

208
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

45%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

57%
prescriptions for brand name drugs

Avg: 44%

$79
Average prescription price

Avg: $89

JAMES DUNN M.D.

Obstetrics Gynecology

994

$63K

211
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

35%
prescriptions for brand name drugs

Avg: 44%

$63
Average prescription price

Avg: $89

CONNIE CHEIN MD

Obstetrics Gynecology

973

$79.2K

180
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

23%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 29%

48%
prescriptions for brand name drugs

Avg: 44%

$81
Average prescription price

Avg: $89

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank